VERA Insider Trading Activity and SEC Form 4 Filings
VERA insider trading summary
Over the past 12 months, insiders at Vera Therapeutics, Inc. (VERA) reported 30 sales worth $11.3M by 8 insiders and 1 open-market purchase worth $250K by 1 insider on SEC Form 4. Net insider selling was $11.1M.
Latest VERA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Marshall Fordyce | President and CEO | Sell | $685K (18,500 @ $37.00) |
| Sep 2, 2026 | Marshall Fordyce | President and CEO | Sell | $650K (18,500 @ $35.12) |
| Jul 7, 2026 | Marshall Fordyce | President and CEO | Sell | $41K (1,000 @ $40.78) |
| Jul 7, 2026 | Marshall Fordyce | President and CEO | Sell | $1.4M (32,550 @ $42.07) |
| Jul 7, 2026 | Marshall Fordyce | President and CEO | Sell | $450K (10,500 @ $42.86) |
| Jul 7, 2026 | Marshall Fordyce | President and CEO | Sell | $96K (2,200 @ $43.59) |
| Jul 7, 2026 | Marshall Fordyce | President and CEO | Sell | $450K (10,500 @ $42.86) |
| Jul 7, 2026 | Marshall Fordyce | President and CEO | Sell | $1.4M (32,550 @ $42.07) |
| Jul 7, 2026 | Marshall Fordyce | President and CEO | Sell | $41K (1,000 @ $40.78) |
| Jul 7, 2026 | Marshall Fordyce | President and CEO | Sell | $96K (2,200 @ $43.59) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.